000 01422 a2200337 4500
005 20250513195954.0
264 0 _c20000106
008 200001s 0 0 eng d
022 _a1078-0432
040 _aNLM
_beng
_cNLM
100 1 _aSoares, P
245 0 0 _aCorrespondence re: G. Tallini et al., RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotype. Clin. Cancer Res., 4:287-294, 1998.
_h[electronic resource]
260 _bClinical cancer research : an official journal of the American Association for Cancer Research
_cNov 1999
300 _a3724-5 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAdult
650 0 4 _aCarcinoma, Papillary
_xgenetics
650 0 4 _aDisease Progression
650 0 4 _aDrosophila Proteins
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aGene Rearrangement
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aPhenotype
650 0 4 _aProto-Oncogene Proteins
_xgenetics
650 0 4 _aProto-Oncogene Proteins c-ret
650 0 4 _aReceptor Protein-Tyrosine Kinases
_xgenetics
650 0 4 _aThyroid Neoplasms
_xgenetics
700 1 _aSobrinho-Simões, M
773 0 _tClinical cancer research : an official journal of the American Association for Cancer Research
_gvol. 5
_gno. 11
_gp. 3724-5
999 _c10545951
_d10545951